feedback welcome

Citalopram-duloxetine

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[draft revision][draft revision]
Line 2: Line 2:
| from = citalopram  
| from = citalopram  
| to = duloxetine  
| to = duloxetine  
-
| stop =  
+
| stop = {{StopEscitalopram}}
-
* '''Before day 1:''' gradually reduce dosage of citalopram/escitalopram to a maximum of 20 mg/ day resp. 10 mg/day, when this dosage is respectively > 20 mg/day and > 10 mg/day.
+
-
* '''Day 1:''' reduce dosage of citalopram/escitalopram to a maximum of 10 mg/ day resp. 5 mg/day.
+
-
* '''Day 8:''' stop administration of citalopram/escitalopram.
+
| start =  
| start =  
* '''Day 8:''' start administration of duloxetine in a dosage of 30 mg/day.
* '''Day 8:''' start administration of duloxetine in a dosage of 30 mg/day.
* '''Day 15:''' increase dosage of duloxetine 60 mg/day.  
* '''Day 15:''' increase dosage of duloxetine 60 mg/day.  
| info =
| info =
-
* The same applies to [[escitalopram]].
 
* {{theorSS}}
* {{theorSS}}
}}
}}

Revision as of 20:17, 4 March 2010

Citalopram
Type Antidepressant
Group SSRI
links
ATC-code N06AB04
Medscape Citalopram
PubChem 2771
PubMed Citalopram
Kompas (Dutch) citalopram
Wikipedia citalopram
Duloxetine
Type Antidepressant
Group SNRI
links
Medscape Duloxetine
PubChem 60835
PubMed Duloxetine
Kompas (Dutch) Duloxetine
Wikipedia Duloxetine

Switch medication from citalopram to duloxetine.

Nietinrijdenbord.png Stop citalopram
Eenrichtingbord.png Start duloxetine
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About